Stonehage Fleming Financial Services’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-350	Closed	-$35K	–	242
2021 Q3	$35K	Hold	350	–	–	﹤0.01%	195
2021 Q2	$50K	Buy	+350	New	+$50K	﹤0.01%	172